Related references
Note: Only part of the references are listed.Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages
Benjamin H. Durham
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition
Olive S. Eckstein et al.
BLOOD (2019)
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
Jean Donadieu et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms
Benjamin H. Durham et al.
NATURE MEDICINE (2019)
BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease
J. Picarsic et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor
Rosemarie Mastropolo et al.
BLOOD ADVANCES (2019)
BRAF V600E mutation detected in a case of Rosai-Dorfman disease
Giancarlo Fatobene et al.
HAEMATOLOGICA (2018)
BRAF V600E mutation detected in a case of Rosai-Dorfman disease
Giancarlo Fatobene et al.
HAEMATOLOGICA (2018)
Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome
Michael Rusch et al.
NATURE COMMUNICATIONS (2018)
BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma
Piti Techavichit et al.
HUMAN PATHOLOGY (2017)
Histiocytoses: emerging neoplasia behind inflammation
Julien Haroche et al.
LANCET ONCOLOGY (2017)
Activating MAPK1 (ERK2) mutation in an aggressive case of disseminated juvenile xanthogranuloma
Rikhia Chakraborty et al.
ONCOTARGET (2017)
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study)
Fleur Cohen Aubart et al.
BLOOD (2017)
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children's Oncology Group
Shalini C. Reshmi et al.
BLOOD (2017)
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
Eli L. Diamond et al.
CANCER DISCOVERY (2016)
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
J.-F. Emile et al.
BLOOD (2016)
Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease
Julien Haroche et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders
Carl E. Allen et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2015)
Gene expression profiling of human monocyte-derived dendritic cells - searching for molecular regulators of tolerogenicity
Katina Schinnerling et al.
FRONTIERS IN IMMUNOLOGY (2015)
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
K. G. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Successful tyrosine kinase inhibitor therapy in a refractory B-cell precursor acute lymphoblastic leukemia with EBF1-PDGFRB fusion
Etienne Lengline et al.
HAEMATOLOGICA (2013)
Tyrosine Kinase Inhibitor Therapy Induces Remission in a Patient With Refractory EBF1-PDGFRB-Positive Acute Lymphoblastic Leukemia
Brent W. Weston et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Juvenile xanthogranulomas of the nervous system: A report of two cases and review of the literature
Jeremy K. Deisch et al.
NEUROPATHOLOGY (2013)
Transforming Growth Factor β Inhibits Platelet Derived Growth Factor-Induced Vascular Smooth Muscle Cell Proliferation via Akt-Independent, Smad-Mediated Cyclin D1 Downregulation
Abel Martin-Garrido et al.
PLOS ONE (2013)
Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis
Gabriel C. Caponetti et al.
HUMAN PATHOLOGY (2012)
Recurrent BRAF mutations in Langerhans cell histiocytosis
Gayane Badalian-Very et al.
BLOOD (2010)
Successful Treatment of Central Nervous System Juvenile Xanthogranulomatosis With Cladribine
Barathi Rajendra et al.
PEDIATRIC BLOOD & CANCER (2009)
Systemic Juvenile Xanthogranuloma with Fatal Outcome
Daniel Azorin et al.
PEDIATRIC DERMATOLOGY (2009)
Imatinib mesylate for platelet-derived growth factor receptor-beta-positive Erdheim-Chester histiocytosis
Julien Haroche et al.
BLOOD (2008)
Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses
Jochen Utikal et al.
ARCHIVES OF DERMATOLOGY (2007)
Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics
F Le Naour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
